This study tests a new drug called EVO756 in 160 adults with moderate to severe chronic hives that don't get better with standard allergy medicines. Participants will receive either EVO756 or a placebo to see if the drug reduces itching and hives. The goal is to find a safe and e…
Phase: PHASE2 • Sponsor: Evommune, Inc. • Aim: Symptom relief
Last updated May 17, 2026 11:49 UTC